Morgan Stanley »

Acurx Pharmaceuticals shares owned by Morgan Stanley

Quarter-by-quarter ownership of Acurx Pharmaceuticals shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Acurx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acurx Pharmaceuticals held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acurx Pharmaceuticals by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2025-06-30 $54k 106k 0.51
2024-12-31 $86k 106k 0.81
2024-09-30 $88k 46k 1.90
2024-06-30 $104k 46k 2.25
2024-03-31 $65k 26k 2.45
2023-12-31 $62k 16k 3.83
2023-09-30 $23k 15k 1.50

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Morgan Stanley

Top funds holding Acurx Pharmaceuticals

Morgan Stanley
Advisor Group Holdings
Semmax Financial Advisors

View all funds holding Acurx Pharmaceuticals